|
MYO5C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.99259974976007E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.97290000020823E-07 |
| Normal-vs-Stage2 |
1.65693999999439E-05 |
| Normal-vs-Stage3 |
2.2681999944929E-08 |
| Normal-vs-Stage4 |
1.204430E-04 |
| Stage1-vs-Stage2 |
4.196400E-01 |
| Stage1-vs-Stage3 |
7.134000E-02 |
| Stage1-vs-Stage4 |
1.942610E-01 |
| Stage2-vs-Stage3 |
6.096000E-01 |
| Stage2-vs-Stage4 |
6.430800E-01 |
| Stage3-vs-Stage4 |
8.778600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.03630001749389E-09 |
| Normal-vs-AfricanAmerican |
3.71570000001764E-06 |
| Normal-vs-Asian |
2.70570000004966E-06 |
| Caucasian-vs-AfricanAmerican |
5.404800E-01 |
| Caucasian-vs-Asian |
5.652200E-01 |
| AfricanAmerican-vs-Asian |
3.499800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.71906933132959E-12 |
| Normal-vs-Female |
1.535890E-03 |
| Male-vs-Female |
4.078300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.65170000010484E-07 |
| Normal-vs-Extreme_Weight |
1.41439999712389E-08 |
| Normal-vs-Obese |
1.73243999999073E-05 |
| Normal-vs-Extreme_Obese |
8.996300E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.070800E-01 |
| Normal_Weight-vs-Obese |
2.719000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.121800E-01 |
| Extreme_Weight-vs-Obese |
1.708960E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.768200E-01 |
| Obese-vs-Extreme_Obese |
7.997000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.556100E-03 |
| Normal-vs-Age(41-60Yrs) |
5.00439999995272E-07 |
| Normal-vs-Age(61-80Yrs) |
1.0184999510443E-09 |
| Normal-vs-Age(81-100Yrs) |
9.94159998768396E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.174200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.730800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.655600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.111700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.896010E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.385700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.85660051169145E-10 |
| Normal-VS-Type2 PRCC |
8.11617439921974E-12 |
| Normal-VS-KIRP CIMP |
4.848400E-02 |
| Normal-VS-Unclassified PRCC |
1.611450E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.344300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.362770E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.956400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.146140E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.009400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.833200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.17640003189013E-09 |
| Normal-vs-N1 |
3.41459999997351E-06 |
| Normal-vs-N2 |
7.263200E-03 |
| N0-vs-N1 |
3.416300E-02 |
| N0-vs-N2 |
7.820800E-01 |
| N1-vs-N2 |
2.823000E-01 |
|
|
